TER stock sentiment todayTeradyne, Inc.
Sentiment verdict
Gossip first, financials second — NEUTRAL at 75% confidence.
Last updated · cached analysis, refreshes periodically
TER
Teradyne, Inc.Teradyne is caught in a 'sell the news' cycle where strong AI-driven earnings are overshadowed by a premium valuation and a sluggish recovery in its robotics segment.
Pick a name and you can add your own 1-, 3- and 6-month price calls — no account needed. The needle above shows where the crowd sits. Calls lock 48 hours after you make them, so every scorecard stays honest.
You'll show up on boards and The Floor under this name. Add an email later to keep your history.
No account needed. You can add an email later to keep your calls.
Already have an account? Sign in
See exactly how analyst targets, gossip sentiment and momentum are weighted into this 6-month forecast.
Sign in to go Pro →Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for TER. Not financial advice.
Price · last 12 months
Gossip
The market narrative is polarized; while Teradyne is beating Q3 expectations fueled by AI chip-testing demand, the stock is facing a 'tech bloodbath' sell-off. Analysts are questioning if the AI tailwinds are already priced in, leading to concerns that the stock is currently trading above fair value despite solid fundamentals.
- ·AI-driven demand for semiconductor testing
- ·Post-earnings profit taking
- ·Broad Nasdaq volatility
- ·Slow recovery in the Universal Robots (Robotics) division
Financial
Teradyne maintains a fortress balance sheet with high gross margins (~57%) and strong free cash flow. While the Semi Test business is surging due to complex HBM (High Bandwidth Memory) and SoC testing needs, the high P/E ratio relative to historical norms suggests limited near-term upside.
- ·Gross Margin: ~57%
- ·P/E Ratio: ~35-40x (Forward)
- ·Debt-to-Equity: Very low (<0.2)
- ·Q3 Earnings: Beat on EPS and Revenue
Conviction
Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.
Strong conviction — insiders and patient capital are backing this.
- ·No open-market insider trades in the last 120 days.
Pro shows every named insider trade in the window (buyer, title, size, price, and whether it was a pre-scheduled 10b5-1 sale) plus the full holder register split into patient capital and fast money.
Unlock with Pro →Source: SEC EDGAR Form 4 + 13F holder register. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.
Risks
- ·Cyclical downturn in the broader smartphone/PC end-markets
- ·Stagnant growth in the industrial automation/robotics segment
- ·Geopolitical trade restrictions on semiconductor equipment to China
- ·High valuation sensitivity to interest rate fluctuations
Peer temperature
How direct competitors stack up against TER right now.
- HOTASLYYAdvantest Corporation
HOTTER — Direct rival in ATE (Automated Test Equipment) with higher exposure to the Nvidia/HBM supply chain and currently seeing more aggressive momentum in Japan.
See full analysis → - HOTKLACKLA Corporation
HOTTER — Offers superior operating margins and a dominant 'toll-booth' position in process control that is less cyclical than Teradyne's back-end testing.
See full analysis → - NEUTRALAMATApplied Materials
NEUTRAL — Similar exposure to WFE (Wafer Fab Equipment) spending cycles but faces comparable headwinds in China revenue concentration.
See full analysis →
- TER-31.6%
- ASLYY—
- KLAC-19.0%
- AMAT-23.7%
Analyst price target
Consensus average of 12 analysts · median 440.00
Source: StockAnalysis.com · updated 2026-10-29
Recent headlines
- Yahoo FinanceTeradyne (TER) Dropped, So What Is Behind The Latest Attention?
- Investor's Business DailyTeradyne Stock Falls Despite Chip-Gear Maker Beating Q3 Goals
- Simply Wall StTeradyne (Nasdaq:TER) - Stock Analysis
- Seeking AlphaNasdaq tanks 5% in October as tech bloodbath deepens (TER:NASDAQ)
- Yahoo FinanceTeradyne (TER) Stock May Be Above Fair Value Despite Record AI Demand
- Seeking AlphaTeradyne stock falls despite Q3 earnings beat, strong AI-driven outlook (TER:NASDAQ)
AI-generated analysis for informational purposes only. Not financial advice.